Heins Mills & Olson

Heins Mills & Olson, P.L.C. is a Minneapolis-based law firm specializing in complex litigation, with a significant focus on antitrust, consumer protection, and securities fraud. The firm is widely recognized for its leadership in pharmaceutical antitrust class actions, representing consumers and end-payors in high-stakes litigation against major drug manufacturers. These legal actions typically target anticompetitive practices such as 'pay-for-delay' agreements that hinder the entry of generic medications into the market. Since its establishment in 1994, the firm has recovered over $3 billion for its clients and has been involved in landmark cases concerning drugs like Suboxone, Lidoderm, and Aggrenox. Heins Mills & Olson is frequently appointed as lead or co-lead counsel in national class action suits.